|
"hsu c"的相關文件
顯示項目 776-800 / 881 (共36頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2011 |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Cheng A.L.; YEN-SHEN LU; Kuo W.H; Chen I.C; Lin C.H; Huang C.S; Lien H.C; Hsu C; Chen I.C;Lin C.H;Huang C.S;Lien H.C;Hsu C;Kuo W.H;Yen-Shen Lu;Cheng A.L. |
| 臺大學術典藏 |
2011 |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Chen B.-B.; Hsu C.-H.; Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Wei S.-Y.; Cheng A.-L.; TIFFANY TING-FANG SHIH |
| 國家衛生研究院 |
2010-01-30 |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko, BS;Chang, TC;Chen, CH;Liu, CC;Kuo, CC;Hsu, C;Shen, YC;Shen, TL;Golubovskaya, VM;Chang, CC;Shyue, SK;Liou, JY |
| 國家衛生研究院 |
2010 |
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
|
Shen, YC;Hsu, C;Chen, LT;Cheng, CC;Hu, FC;Cheng, AL |
| 國家衛生研究院 |
2009-10 |
Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma
|
Jan, YJ;Ko, BS;Hsu, C;Chang, TC;Chen, SC;Wang, J;Liou, JY |
| 國家衛生研究院 |
2009-09-15 |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2009-05-20 |
Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application
|
Kuo, S;Chen, L;Wu, M;Hsu, C;Lin, C;Hsu, P;Yeh, K;Tzeng, Y;Cheng, A |
| 國家衛生研究院 |
2009-04-24 |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL |
| 國立臺灣大學 |
2009-04 |
Frame Misalignment: Interpreting the Implementation of Information Systems Security Certification in an Organization
|
Hsu, C. |
| 國立臺灣大學 |
2009-03 |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma.
|
Lin, ZZ; Hsu, HC; Hsu, CH; Yeh, PY; Huang, CY; Huang, YF; Chen, TJ; Kuo, SH; Hsu, C; Hu, FC; Jeng, YM; Chung, Y; Cheng, AL. |
| 國家衛生研究院 |
2009-02 |
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival
|
Shen, YC;Hu, FC;Jeng, YM;Chang, YT;Lin, ZZ;Chang, MC;Hsu, C;Cheng, AL |
| 國家衛生研究院 |
2009 |
Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis
|
Hsu, C;Shen, Y;Chen, L;Cheng, C;Hu, F;Cheng, A |
| 高雄醫學大學 |
2009 |
軟珊瑚Nephthea erecta and N. chabrolizp 分離純化的sesquiterpenes and norergosterol
|
鄭旭益;溫世宏;邱素芬;王雙桂;戴昌鳳;杜昌益 ; Cheng SY;Huang YC;Wen ZH;Chiou SF;Wang SK;Hsu C;Dai CF;Duh CY |
| 國立臺灣大學 |
2009 |
Creating Experience Economy in E-Commerce
|
Chang, W.; Yuan, S.T.; Hsu, C. |
| 臺大學術典藏 |
2009 |
Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy
|
Chen P.-J.; Cheng A.-L.; SHU-CHEN WEI; Hsu C. |
| 國家衛生研究院 |
2008-12 |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu, C;Kuo, SH;Hu, FC;Cheng, AL;Shih, JY;Yu, CJ;Lin, CC;Huang, TC;Yang, PC;Yang, CH |
| 國立政治大學 |
2008-12 |
Teachers’ perceptions of the dimensions and implementation of technology leadership of principals in Taiwanese elementary schools
|
Chang, I.;秦夢群;Hsu, C.; Chang, I.;Chin, J.M.;Hsu, C. |
| 元智大學 |
2008-05 |
線上遊戲設計: 分析架構與個案探討
|
邱昭彰; Jen, E F; Hsu, C. |
| 國家衛生研究院 |
2008-03 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
|
Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Chao, TY; Liu, TW; Cheng, AL; Chen, PJ |
| 國立臺灣大學 |
2008-03 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial.
|
Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ |
| 國立臺灣大學 |
2008-03 |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by international prognostic scoring system, cytogenetic and genetic studies.
|
Huang, TC; Ko, BS; Hsu, C; Chen, CY; Tsay, W; Tang, JL; Huang, SY; Yao, M; Chen, YC; Shen, MC; Wang, CH; Tien, HF |
| 國家衛生研究院 |
2008 |
Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment
|
Hsu, C;Chen, LT;Chao, Y;Fan, HH;Shen, YC;Cheng, AL |
| 臺北醫學大學 |
2008 |
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
|
鄭建睿; Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC |
| 臺大學術典藏 |
2008 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
CHIH-HSIN YANG; Yang P.-C; Cheng A.-L; Lin C.-C; Hsu C.-H; Yu C.-J; Chang Y.-C; Chih-Hsin Yang;Yang P.-C;Cheng A.-L;Lin C.-C;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C |
| 臺大學術典藏 |
2008 |
Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers
|
Hsu C.; JIN-YUAN SHIH; Yang C.-H.; Yu C.-J.; Lo Y.; Chen J.-P. |
顯示項目 776-800 / 881 (共36頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目
|
